Haemostatic changes in pregnancy (Q73429692)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763484%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

Haemostatic changes in pregnancy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763484%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Katarina A Bremme

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763484%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763484%20AND%20SRC:MED&resulttype=core&format=json

Best Practice and Research: Clinical Haematology

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763484%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763484%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763484%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

153-168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763484%20AND%20SRC:MED&resulttype=core&format=json

Predictive value of increased plasma levels of fibronectin in gestational hypertension

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

The function of elevated plasma fibronectin in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Platelet count at term pregnancy: a reappraisal of the threshold

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Platelet disorders in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Gestational thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Platelet lifespan in normal pregnancy as determined by a nonradioisotopic technique

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Correlation between grade III placenta and plasma antithrombin III activity in full term pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Protein C levels in late pregnancy, postpartum and in women on oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Changes in protein C and protein S levels in normal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Comparison of protein S functional and antigenic assays in normal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Development of resistance to activated protein C during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Activated protein C sensitivity ratio in pregnant women at delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Variability of the response to activated protein C during normal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Resistance to activated protein C: evaluation of three functional assays

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Changes in activated protein C resistance during normal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Decrease in protein C inhibitor activity and acquired APC resistance during normal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Acquired activated protein C resistance in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Effect of in vitro fertilization treatment and subsequent pregnancy on the protein C pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Reactivity against phospholipids during pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Marked variation in antiphospholipid antibodies during pregnancy: relationships to pregnancy outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Guidelines on the investigation and management of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

t-PA activity in peripheral blood obtained from pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Enhanced thrombin generation in normal and hypertensive pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Reference interval of D-dimer in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Quantitation of thrombin-antithrombin III complexes in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Soluble fibrin in plasma as a sign of activated coagulation in patients with pregnancy complications

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Blood clotting activation during normal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Thrombin regulation in mother and fetus during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, treatment in pregnant women with previous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

TAFI antigen and D-dimer levels during normal pregnancy and at delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Changes in blood coagulation and fibrinolysis during the puerperium

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Post partum platelet count in maternal blood

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Reactive thrombocytosis after caesarean section and vaginal delivery: implications for maternal thromboembolism and its prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Antithrombin III in normal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Thrombin-inhibitor complexes in the blood during and after delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

Changes in blood coagulation and fibrinolysis in the normal puerperium

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6926%2803%2900021-5

7 January 2021

10.1016/S1521-6926(03)00021-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763484%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference